Nevertheless, growth stocks outperformed value stocks in 2024, and investors anticipate that trend will continue as the Federal Reserve cuts interest rates. Here are 10 of CFRA analysts' top growth stocks that have reported at least 15% annual revenue growth in the past three years:

Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone optimization market.

These stocks are all trading near their 52-week lows, and could be attractive options to consider. They all possess promising growth opportunities in the long run. A $5,000 investment can go a long way,

These characteristics make dividend growth stocks compelling investments in any market environment. The strategy's success stems from the financial discipline and steady execution these companies demonstrate,

Broadcom (NASDAQ: AVGO) is a semiconductor company that's carved out a niche in application-specific integrated circuits (ASICs). Goldman Sachs is estimating that generative AI spending could reach $1 trillion in the next few years.